Abstract

Impaired functional plasma membrane (PM) expression of the hERG K+-channel is associated with Long-QT syndrome type-2 (LQT2) and increased risk of cardiac arrhythmia. Reduced PM-expression is primarily attributed to retention and degradation of misfolded channels by endoplasmic reticulum (ER) protein quality control (QC) systems. However, as the molecular pathogenesis of LQT2 was defined using severely-misfolded hERG variants with limited PM-expression, the potential contribution of post-ER (peripheral) QC pathways to the disease phenotype remains poorly established. Here, we investigate the cellular processing of mildly-misfolded Per-Arnt-Sim (PAS)-domain mutant hERGs, which display incomplete ER-retention and PM-expression defects at physiological temperature. We show that the attenuated PM-expression of hERG is dictated by mutation-specific contributions from both the ER and peripheral QC systems. At the ER, PAS-mutants experience inefficient conformational maturation coupled with rapid ubiquitin-dependent proteasomal degradation. In post-ER compartments, they are rapidly endocytosed from the PM via a ubiquitin-independent mechanism and rapidly targeted for lysosomal degradation. Conformational destabilization underlies aberrant cellular processing at both ER- and post-ER compartments, since conformational correction by a hERG-specific pharmacochaperone or low-temperatures can restore WT-like trafficking. Our results demonstrate that the post-ER QC alone or jointly with the ER QC determines the loss-of-PM-expression phenotype of a subset of LQT2 mutations.

Details

Title
Mutation-specific peripheral and ER quality control of hERG channel cell-surface expression
Author
Foo, Brian 1 ; Barbier, Camille 1 ; Guo, Kevin 2 ; Jaminie, Vasantharuban 3 ; Lukacs, Gergely L 4 ; Shrier, Alvin 1 

 McGill University, Department of Physiology, Montréal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
 McGill University, Department of Physiology, Montréal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Department of Biochemistry, Montréal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); Institut de Recherches Cliniques de Montréal (IRCM), Montréal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357) 
 McGill University, Department of Physiology, Montréal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); Avara Pharmaceutical Services, Boucherville, Canada (GRID:grid.14709.3b) 
 McGill University, Department of Physiology, Montréal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Department of Biochemistry, Montréal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2210009784
Copyright
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.